Holst, Frederik
Hoivik, Erling A.
Gibson, William J.
Taylor-Weiner, Amaro
Schumacher, Steven E.
Asmann, Yan W.
Grossmann, Patrick
Trovik, Jone
Necela, Brian M.
Thompson, E. Aubrey
Meyerson, Matthew
Beroukhim, Rameen
Salvesen, Helga B.
Cherniack, Andrew D.
Article History
Received: 24 August 2015
Accepted: 15 April 2016
First Online: 10 May 2016
Change Date: 24 June 2016
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has been fixed in the paper.
Change Date: 30 June 2017
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Competing interests
: Frederik Holst has royalty interest associated with intellectual property of ZytoVision GmbH concerning patent US8101352B2 “Detection of ESR1 Amplification in Breast Cancer” and according EU patent application. Mathew Meyerson and Andrew Cherniack receive research support from Bayer AG.